In late‐stage colon cancer, tumor‐infiltrating hILC1s showed lower frequencies with reduced IFN‐γ production and high levels of inhibitory receptors,33 suggesting that tumor protective hILC1s can become dysfunctional during cancer progression. The gene discussed is IFNG; the disease is neoplasm.